GERON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.93 USD | -0.51% |
|
+3.69% | +86.26% |
| 05-03 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
| 05-02 | Geron Shares Decline After Q1 Loss Widens | MT |
Chart calendar Geron Corporation
206231f206464c5615c.Uh4l4wyPNwNWvNa90zOV6aNnsGsOhLeggExjerFf0oM.FVhmtn3kXGcZ74zosEHHiPctwhF34u3SwR4QKdQUkLMUUESbdO1nZgnrhw~153c6164dff8d47a9bf2cd7e4661f932
Upcoming events on Geron Corporation
Past events on Geron Corporation
| 02/05/2024 13:00 | Q1 2024 Earnings Call |
| 02/05/2024 12:00 | Q1 2024 Earnings Release |
| 17/04/2024 16:30 | Stifel Virtual Targeted Oncology Days Conference |
| 10/04/2024 15:15 | Needham Healthcare Conference |
| 28/02/2024 13:00 | Q4 2023 Earnings Call |
| 28/02/2024 12:05 | Q4 2023 Earnings Release |
| 18/01/2024 15:30 | B. Riley Securities Oncology Conference - Track 1 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract #2440 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract #4603 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract #4605 |
| 09/12/2023 22:15 | American Society of Hematology Meeting - Abstract #194 |
| 29/11/2023 15:50 | Evercore ISI HealthCONx Conference |
| 28/11/2023 14:30 | Piper Sandler Healthcare Conference |
| 14/11/2023 14:10 | Stifel Healthcare Conference |
| 02/11/2023 13:00 | Q3 2023 Earnings Call |
| 01/11/2023 | Q3 2023 Earnings Release Pre-market |
| 12/09/2023 21:55 | Baird Global Healthcare Conference |
| 03/08/2023 21:30 | Q2 2023 Earnings Call |
| 03/08/2023 21:00 | Q2 2023 Earnings Release |
| 15/06/2023 16:40 | Goldman Sachs Global Healthcare Conference |
Past dividends on Geron Corporation
| 21/07/2014 | 0 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,46 0,36 26.23% | 0,25 0,24 3.62% | 1,39 0,42 228.38% | 0,60 0,61 -2.08% | 0,24 0,30 -19.8% | 55,0 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -194 -201 3.64% | -215 |
|
EBIT Million USD | Released Forecast Spread | -72,5 -82,3 11.9% | -76,9 -74,7 -3.01% | -114 -110 -3.32% | -139 -146 5.33% | -194 -201 3.69% | -222 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -68,5 -78,6 12.76% | -75,6 -72,0 -5.03% | -116 -111 -4.32% | -142 -149 4.45% | -184 -194 4.88% | -219 |
|
Net income Million USD | Released Forecast Spread | -68,5 -78,9 13.15% | -75,6 -72,7 -4.07% | -116 -112 -4.05% | -142 -150 5.49% | -184 -196 5.97% | -219 |
|
EPS USD | Released Forecast Spread | -0,36 -0,42 14.29% | -0,28 -0,27 -5% | -0,35 -0,34 -2.94% | -0,37 -0,39 4.31% | -0,32 -0,35 7.51% | -0,35 |
| Announcement Date | 12/03/20 | 11/03/21 | 10/03/22 | 16/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,04 0,06 1582.85% | 0,12 0,10 20.29% | 0,07 0,11 -36.3% | 0,30 0,09 240.71% | 0,10 0,12 -17.27% | 0,02 0,08 -73.64% | 0,03 0,08 -63.38% | 0,16 0,07 131.64% | 0,02 0,10 -76.48% | 0,30 0,02 1130.27% | 0,00 | 21,4 | 40,8 | 52,1 |
|
EBIT Million USD | Released Forecast Spread | -31,0 -27,3 -13.39% | -28,7 -34,2 16.27% | -28,0 -34,5 18.82% | -39,9 -37,1 -7.66% | -42,0 -49,7 15.67% | -40,1 -46,4 13.53% | -52,0 -47,0 -10.53% | -47,6 -57,5 17.18% | -54,3 -61,7 12.04% | -56,1 -58,4 3.92% | -67,8 | -53,0 | -40,1 | -32,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,0 -27,2 -17.56% | -30,1 -34,7 13.34% | -28,1 -34,8 19.19% | -41,1 -37,2 -10.46% | -42,6 -49,2 13.4% | -38,1 -47,1 19.14% | -49,2 -46,4 -6.04% | -44,8 -57,3 21.82% | -52,0 -59,5 12.7% | -55,4 -56,7 2.28% | -66,8 | -52,3 | -38,9 | -34,8 |
|
Net income Million USD | Released Forecast Spread | -32,0 -27,5 -16.34% | -30,1 -35,3 14.63% | -28,1 -35,6 21.05% | -41,1 -38,1 -7.87% | -42,6 -50,9 16.18% | -38,1 -50,4 24.3% | -49,2 -48,7 -1.06% | -44,8 -58,6 23.59% | -52,0 -61,8 15.89% | -55,4 -56,8 2.51% | -66,2 | -52,4 | -40,5 | -40,0 |
|
EPS USD | Released Forecast Spread | -0,10 -0,08 -19.05% | -0,09 -0,11 14.29% | -0,07 -0,09 25.53% | -0,10 -0,09 -7.15% | -0,10 -0,13 20% | -0,07 -0,10 31.37% | -0,09 -0,09 -4.65% | -0,08 -0,10 21.57% | -0,09 -0,10 13.46% | -0,09 -0,10 6.9% | -0,10 | -0,09 | -0,06 | -0,05 |
| Announcement Date | 10/03/22 | 09/05/22 | 11/08/22 | 03/11/22 | 16/03/23 | 11/05/23 | 03/08/23 | 02/11/23 | 28/02/24 | 02/05/24 | - | - | - | - |
More events
Past sector events for Geron Corporation
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GERN Stock
- Calendar Geron Corporation
